{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:44:19Z","timestamp":1785386659220,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Growing Stronger Foundation"},{"DOI":"10.13039\/100012465","name":"Nemours Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011781","name":"Shriners Hospitals for Children","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AR065657"],"award-info":[{"award-number":["R21AR065657"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1106834"],"award-info":[{"award-number":["OPP1106834"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00223-022-00966-0","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T07:03:01Z","timestamp":1646982181000},"page":"66-72","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Collagen X Marker Levels are Decreased in Individuals with Achondroplasia"],"prefix":"10.1007","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9221-4879","authenticated-orcid":false,"given":"Ricki S.","family":"Carroll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4937-3567","authenticated-orcid":false,"given":"Robert C.","family":"Olney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2204-4659","authenticated-orcid":false,"given":"Angela L.","family":"Duker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6318-9870","authenticated-orcid":false,"given":"Ryan F.","family":"Coghlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6847-1197","authenticated-orcid":false,"given":"William G.","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0708-5196","authenticated-orcid":false,"given":"Colleen P.","family":"Ditro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5641-2002","authenticated-orcid":false,"given":"Cassondra J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9802-4622","authenticated-orcid":false,"given":"David A.","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5742-7377","authenticated-orcid":false,"given":"William A.","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7786-2870","authenticated-orcid":false,"given":"Brian","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3318-3929","authenticated-orcid":false,"given":"Eric A.","family":"Espiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9684-5096","authenticated-orcid":false,"given":"Timothy C. R.","family":"Prickett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6178-1264","authenticated-orcid":false,"given":"Michael B.","family":"Bober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,11]]},"reference":[{"issue":"4","key":"966_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/dvdy.24479","volume":"246","author":"DM Ornitz","year":"2017","unstructured":"Ornitz DM, Legeai-Mallet L (2017) Achondroplasia: development, pathogenesis, and therapy. Dev Dyn 246(4):291\u2013309. https:\/\/doi.org\/10.1002\/dvdy.24479","journal-title":"Dev Dyn"},{"issue":"3","key":"966_CR2","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/j.1365-2265.2012.04392.x","volume":"77","author":"RC Olney","year":"2012","unstructured":"Olney RC, Permuy JW, Prickett TC, Han JC, Espiner EA (2012) Amino-terminal propeptide of C-type natriuretic peptide (ntprocnp) predicts height velocity in healthy children. Clin Endocrinol (Oxf) 77(3):416\u2013422. https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04392.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"966_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1159\/000496544","volume":"90","author":"E Espiner","year":"2018","unstructured":"Espiner E, Prickett T, Olney R (2018) Plasma C-type natriuretic peptide: emerging applications in disorders of skeletal growth. Horm Res Paediatr 90(6):345\u2013357. https:\/\/doi.org\/10.1159\/000496544","journal-title":"Horm Res Paediatr"},{"issue":"Pt 21","key":"966_CR4","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.1242\/jcs.02618","volume":"118","author":"P Krejci","year":"2005","unstructured":"Krejci P, Masri B, Fontaine V, Mekikian PB, Weis M, Prats H, Wilcox WR (2005) Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis. J Cell Sci 118(Pt 21):5089\u20135100. https:\/\/doi.org\/10.1242\/jcs.02618","journal-title":"J Cell Sci"},{"issue":"2","key":"966_CR5","doi-asserted-by":"publisher","first-page":"E355","DOI":"10.1210\/jc.2014-2814","volume":"100","author":"RC Olney","year":"2015","unstructured":"Olney RC, Prickett TC, Espiner EA, Mackenzie WG, Duker AL, Ditro C, Zabel B et al (2015) C-type natriuretic peptide plasma levels are elevated in subjects with achondroplasia, hypochondroplasia, and thanatophoric dysplasia. J Clin Endocrinol Metab 100(2):E355\u2013E359. https:\/\/doi.org\/10.1210\/jc.2014-2814","journal-title":"J Clin Endocrinol Metab"},{"issue":"419","key":"966_CR6","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1126\/scitranslmed.aan4669","volume":"9","author":"RF Coghlan","year":"2017","unstructured":"Coghlan RF, Oberdorf JA, Sienko S, Aiona MD, Boston BA, Connelly KJ, Bahney C et al (2017) A degradation fragment of type X collagen is a real-time marker for bone growth velocity. Sci Transl Med 9(419):4669. https:\/\/doi.org\/10.1126\/scitranslmed.aan4669","journal-title":"Sci Transl Med"},{"issue":"1","key":"966_CR7","doi-asserted-by":"publisher","first-page":"e255","DOI":"10.1210\/clinem\/dgaa721","volume":"106","author":"RF Coghlan","year":"2021","unstructured":"Coghlan RF, Olney RC, Boston BA, Coleman DT, Johnstone B, Horton WA (2021) Norms for clinical use of CXM, a real-time marker of height velocity. J Clin Endocrinol Metab 106(1):e255\u2013e264. https:\/\/doi.org\/10.1210\/clinem\/dgaa721","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"966_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1056\/NEJMoa1813446","volume":"381","author":"R Savarirayan","year":"2019","unstructured":"Savarirayan R, Irving M, Bacino CA, Bostwick B, Charrow J, Cormier-Daire V, Le Quan Sang KH et al (2019) C-Type natriuretic peptide analogue therapy in children with achondroplasia. N Engl J Med 381(1):25\u201335. https:\/\/doi.org\/10.1056\/NEJMoa1813446","journal-title":"N Engl J Med"},{"issue":"3","key":"966_CR9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2307\/2347802","volume":"36","author":"RW Koenker","year":"1987","unstructured":"Koenker RW, d\u2019Orey V (1987) Algorithm as 229: computing regression quantiles. J R Stat Soc Ser C Appl Stat 36(3):383\u2013393. https:\/\/doi.org\/10.2307\/2347802","journal-title":"J R Stat Soc Ser C Appl Stat"},{"issue":"9","key":"966_CR10","doi-asserted-by":"publisher","first-page":"147832","DOI":"10.1172\/jci.insight.147832","volume":"6","author":"BM Wagner","year":"2021","unstructured":"Wagner BM, Robinson JW, Lin YW, Lee YC, Kaci N, Legeai-Mallet L, Potter LR (2021) Prevention of guanylyl cyclase-B dephosphorylation rescues achondroplastic dwarfism. JCI Insight 6(9):147832. https:\/\/doi.org\/10.1172\/jci.insight.147832","journal-title":"JCI Insight"},{"issue":"1","key":"966_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/nm971","volume":"10","author":"A Yasoda","year":"2004","unstructured":"Yasoda A, Komatsu Y, Chusho H, Miyazawa T, Ozasa A, Miura M, Kurihara T et al (2004) Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat Med 10(1):80\u201386. https:\/\/doi.org\/10.1038\/nm971","journal-title":"Nat Med"},{"issue":"8","key":"966_CR12","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/ajmg.a.38853","volume":"176","author":"A Merker","year":"2018","unstructured":"Merker A, Neumeyer L, Hertel NT, Grigelioniene G, Makitie O, Mohnike K, Hagenas L (2018) Growth in achondroplasia: development of height, weight, head circumference, and body mass index in a European cohort. Am J Med Genet A 176(8):1723\u20131734. https:\/\/doi.org\/10.1002\/ajmg.a.38853","journal-title":"Am J Med Genet A"},{"issue":"1","key":"966_CR13","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1186\/s13023-021-02141-4","volume":"16","author":"JE Hoover-Fong","year":"2021","unstructured":"Hoover-Fong JE, Schulze KJ, Alade AY, Bober MB, Gough E, Hashmi SS, Hecht JT et al (2021) Growth in achondroplasia including stature, weight, weight-for-height and head circumference from CLARITY: achondroplasia natural history study\u2013a multi-center retrospective cohort study of achondroplasia in the US. Orphanet J Rare Dis 16(1):522. https:\/\/doi.org\/10.1186\/s13023-021-02141-4","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"966_CR14","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.bone.2005.03.006","volume":"36","author":"A Ozasa","year":"2005","unstructured":"Ozasa A, Komatsu Y, Yasoda A, Miura M, Sakuma Y, Nakatsuru Y, Arai H et al (2005) Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells. Bone 36(6):1056\u20131064. https:\/\/doi.org\/10.1016\/j.bone.2005.03.006","journal-title":"Bone"},{"issue":"6","key":"966_CR15","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/ajmg.a.61120","volume":"179","author":"M Del Pino","year":"2019","unstructured":"Del Pino M, Fano V, Adamo P (2019) Height growth velocity in infancy and childhood in achondroplasia. Am J Med Genet A 179(6):1001\u20131009. https:\/\/doi.org\/10.1002\/ajmg.a.61120","journal-title":"Am J Med Genet A"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-022-00966-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-022-00966-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-022-00966-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T12:07:23Z","timestamp":1656072443000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-022-00966-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,11]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["966"],"URL":"https:\/\/doi.org\/10.1007\/s00223-022-00966-0","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,11]]},"assertion":[{"value":"29 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CJB, ALD, BJ, DAO\u2019C, RCO have no disclosure information relevant to this work. CPD received lecture fees from BioMarin. RFC & WAH are inventors on a patent entitled, \u201cType X collagen assay and methods of use thereof,\u201d filed by Shriners Hospital for Children. EAE & TCRP have filed a patent entitled, \u201cAssessment of skeletal growth using measurements of NT-CNP peptides.\u201d MBB, RFC, WAH, have consulted for TherAchon\/Pfizer and QED. MBB, RFC, EAE, WAH, WGM have consulted for BioMarin. WAH has consulted for Relay Therapeutics.MBB, WAH have consulted for Ascendis. MBB and RSC receive research funding from Biomarin, TherAchon\/Pfizer, Ascendis, and QED.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The original study was approved by the Nemours Florida Institutional Review Board. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All children had written parental permission obtained. Parental permission forms included authorization to archive and use blood samples for future research studies.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}